Newest first
New topics page 14
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 14 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: How to disagree with an answer you were given, well
How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title. Context below, and I have tried to include…
|
2 | 16k | 30d | |
|
CJC-1295 with and without DAC: what the modification does
On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with SURMOUNT-OSA ( N Engl J Med ,…
|
+117 | 123 | 5.6k | 22h |
|
Follow-up: Patterns that reliably precede a problem, documented
On the subject in the title: Patterns that reliably precede a problem, documented Working notes rather than a conclusion. A logistics question, since the answers here are usually better than anywhere else I…
|
2 | 70 | 1d | |
|
Preservatives: function, testing, and limits — one year on
On the subject in the title: Preservatives: function, testing, and limits — one year on Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. tirzepatide…
|
+28 | 32 | 437 | 8d |
|
A widely repeated interaction claim that turns out to be unsupported — what changed since
A widely repeated interaction claim that turns out to be unsupported — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on…
|
+89 | 94 | 5.9k | 2h |
|
Coming back to: Light exposure: how much protection is proportionate?
Asking directly, because I could not find a straight answer: Light exposure: how much protection is proportionate? Practical question with the units stated, because I have seen how quickly these go wrong…
|
+5 | 10 | 13k | 2d |
|
Preprint servers and what screening they do — the long version
On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
|
+7 | 11 | 26k | 4mo |
|
When a dose reduction is the correct response to a side effect
When a dose reduction is the correct response to a side effect — that is the question, and I have not found it answered plainly anywhere I have looked. A question about technique rather than about dose. I…
|
+38 | 42 | 2.7k | 19h |
|
Revisiting: Maintainer handover: how it works
Revisiting: Maintainer handover: how it works Writing it up because I had to work it out twice and would rather nobody else did. Process question about how this site works. I have read the guidelines and the…
|
+53 | 57 | 664 | 4mo |
|
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
|
+124 | 133 | 11k | 5mo |
|
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
|
2 | 182 | 21h | |
|
[2026 update] Regional warehouse stock versus direct despatch
Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+135 | 147 | 32k | 2d |
|
What other technical communities get right that we do not
What other technical communities get right that we do not — that is the question, and I have not found it answered plainly anywhere I have looked. Lower-stakes topic, but the sourcing rule still applies if…
|
+2 | 6 | 23k | 5h |
|
Why this subcategory is stricter about sourcing than most
Asking directly, because I could not find a straight answer: Why this subcategory is stricter about sourcing than most Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before posting; the…
|
+48 | 52 | 617 | 21d |
|
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on
Asking directly, because I could not find a straight answer: Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Working through the identity arithmetic and I would like it…
|
+10 | 14 | 13k | 5mo |
|
The headache that turns out to be dehydration — the long version
On the subject in the title: The headache that turns out to be dehydration — the long version Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a…
|
+68 | 73 | 1.3k | 12h |
|
About the Special populations category
Older adults, pregnancy and pregnancy planning, adolescents, renal and hepatic impairment, bariatric surgery history. This post is a community wiki: any member at trust level 3 or above can edit it, and every…
|
4 | 3k | 4mo | |
|
Resolution and tailing factor: real acceptance criteria
Resolution and tailing factor: real acceptance criteria Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
2 | 15k | 1mo | |
|
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in support…
|
+120 | 132 | 13k | 1d |
|
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the first three replies will…
|
+104 | 110 | 16k | 2d |
|
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Practical question with the units stated, because I have…
|
+8 | 12 | 4.3k | 1d |
|
About the Doc review category
Review of drafts and revisions before and after promotion. Every promotion is discussed in public. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 25k | 4mo | |
|
Mass error in ppm: the arithmetic and the caveat
Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+108 | 125 | 1.5k | 5mo |
|
[2026 update] Composite endpoints and the component doing the work
On the subject in the title: Composite endpoints and the component doing the work Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet , 2021) and…
|
+76 | 87 | 994 | 3mo |
|
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold?
Asking directly, because I could not find a straight answer: What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold? Session topic: STEP 2 ( Lancet , 2021). Please read…
|
+43 | 47 | 5.5k | just now |
|
Nausea profile of amylin analogues compared with GLP-1 agonists
Nausea profile of amylin analogues compared with GLP-1 agonists Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it…
|
+70 | 76 | 3k | 4mo |
|
Second pass at: Identical chromatograms across two different lots
Posting this under the heading it deserves: Second pass at: Identical chromatograms across two different lots Everything below is what sits behind that. A logistics question, since the answers here are…
|
+81 | 93 | 13k | 4mo |
|
About the HPLC & UHPLC category
Reversed-phase separations, gradients, columns, integration, and reading a chromatogram properly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
4 | 137 | 18h | |
|
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. General question, not a request for advice about my own care —…
|
+81 | 89 | 2.9k | 3mo |
|
A genuinely late dose: what the labelling says and what people do
On the subject in the title: A genuinely late dose: what the labelling says and what people do Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is…
|
2 | 18k | 5mo |